Industry Watch Medical Imaging in Drug

‘Whole body ’ imaging potentially can make fundamental research more useful and help clinicians evaluate new treatments quickly and more effectively. One particular asset to productivity is that because only very low amounts of radiolabeled drug have to be administered for analysis, human studies can be carried out even before the drug is entered into Phase I trials